49 Recruiting Studies Using Everolimus
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Everolimus
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
📍 Alaska Oncology & Hematology, LLC — Anchorage, Alaska
Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
View Study & Checklist ➔Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
📍 Stanford School of Medicine — Stanford, California
Renal Cell Carcinoma
View Study & Checklist ➔Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
📍 Dothan Hematology and Oncology — Dothan, Alabama
Breast Cancer
View Study & Checklist ➔Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
Kidney Cancer
View Study & Checklist ➔CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
Breast Cancer Stage IIB
View Study & Checklist ➔Liver Transplantation With Tregs at MGH
📍 Massachusetts General Hospital: Transplantation — Boston, Massachusetts
Liver Transplant
View Study & Checklist ➔Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
📍 Mayo Clinic in Florida — Jacksonville, Florida
Refractory Hurthle Cell Thyroid Cancer
View Study & Checklist ➔Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
📍 Banner Health d.b.a. Banner MD Anderson Cancer Center — Gilbert, Arizona
Neuroendocrine Tumors
View Study & Checklist ➔S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Breast Cancer
View Study & Checklist ➔A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
📍 Highlands Oncology Group - Duplicate 2 — Rogers, Arkansas
Breast Neoplasms
View Study & Checklist ➔Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
📍 Arizona Oncology Associates Professional Corporation — Tucson, Arizona
Advanced Solid Tumors
View Study & Checklist ➔Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
📍 City of Hope - Phoenix ( Site 0006) — Goodyear, Arizona
Metastatic Breast Cancer
View Study & Checklist ➔Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
📍 Children's Hospital Colorado — Aurora, Colorado
Acute Lymphoblastic Leukemia ALL
View Study & Checklist ➔Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer
📍 Moffitt Cancer Center — Tampa, Florida
Advanced Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
Advanced Cancer
View Study & Checklist ➔A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)
📍 Faculty Office Towers 1132 ( Site 1538) — Birmingham, Alabama
Carcinoma, Renal Cell
View Study & Checklist ➔Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
📍 TGen APNNA — Phoenix, Arizona
Tuberous Sclerosis Complex
View Study & Checklist ➔Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
Soft Tissue Sarcoma
View Study & Checklist ➔A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Breast Cancer
View Study & Checklist ➔Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
Advanced Carcinoid Tumor
View Study & Checklist ➔A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
📍 Hoag Health Center Irvine — Irvine, California
Advanced or Metastatic Breast Cancer
View Study & Checklist ➔A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma
📍 Lyndon Baines Johnson General Hospital — Houston, Texas
Recurrent Endometrial Carcinoma
View Study & Checklist ➔Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer
📍 M D Anderson Cancer Center — Houston, Texas
ALK Positive
View Study & Checklist ➔Itacitinib + Everolimus in Hodgkin Lymphoma
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
Classical Hodgkin Lymphoma
View Study & Checklist ➔Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
📍 Stanford Cancer Center — Palo Alto, California
Neuroendocrine Tumors
View Study & Checklist ➔Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer
📍 North Colorado Medical Center — Greeley, Colorado
Atypical Endometrial Hyperplasia
View Study & Checklist ➔Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations
📍 Stanford University — Stanford, California
Cowden's Disease
View Study & Checklist ➔Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
Advanced Endometrial Carcinoma
View Study & Checklist ➔Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
📍 MD Anderson Cancer Center — Houston, Texas
Phase IB
View Study & Checklist ➔Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
📍 The University of Alabama at Birmingham — Birmingham, Alabama
Pancreatic Neuroendocrine Tumor (pNET)
View Study & Checklist ➔EVR and EPO for Liver Transplant Tolerance
📍 University of California San Francisco School of Medicine — San Francisco, California
Liver Transplant
View Study & Checklist ➔Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
📍 Brigham and Women's Hospital — Boston, Massachusetts
Cutaneous Squamous Cell Carcinoma
View Study & Checklist ➔Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
📍 University of Alabama at Birmingham, Children's of Alabama — Birmingham, Alabama
Recurrent World Health Organization (WHO) Grade II Glioma
View Study & Checklist ➔Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Lung Neuroendocrine Tumor
View Study & Checklist ➔Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
📍 Yale School of Medicine — New Haven, Connecticut
Hormone Receptor-positive Breast Cancer
View Study & Checklist ➔Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Sarcoma
View Study & Checklist ➔Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
📍 Research Facility — Phoenix, Arizona
GEP-NET
View Study & Checklist ➔Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Metastatic Digestive System Neuroendocrine Tumor G1
View Study & Checklist ➔MTOR Inhibitors in Older Adults
📍 UT Southwestern Medical Center — Dallas, Texas
Aging
View Study & Checklist ➔Safety and Durability of Sirolimus for Treatment of LAM
📍 Stanford University Medical Center — Stanford, California
Lymphangioleiomyomatosis
View Study & Checklist ➔Rapalog Pharmacology (RAP PAC) Study
📍 University of Wisconsin — Madison, Wisconsin
Aging
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
📍 City of Hope — Duarte, California
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
View Study & Checklist ➔Pilot Trial for Treatment of Recurrent Glioblastoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
Glioblastoma
View Study & Checklist ➔Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
📍 Mayo Clinic Hospital Arizona (Site #: 71144) — Phoenix, Arizona
Liver Transplant
View Study & Checklist ➔Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Metastatic Breast Cancer
View Study & Checklist ➔A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
Breast Cancer
View Study & Checklist ➔Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
📍 Children's Hospital Colorado — Aurora, Colorado
High Grade Glioma
View Study & Checklist ➔RESTOR: PK/PD mTORi Inhibition in Older Adults
📍 The University of Texas Health Science Center at San Antonio — San Antonio, Texas
Aging
View Study & Checklist ➔Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
📍 Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
Advanced Breast Cancer
View Study & Checklist ➔